Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Egyptian Stocks: Orascom Construction, Maridive and Eipico

Egypt’s benchmark EGX30 Index fell 1.3 percent, the most in more than a month, to 4,890.3 at the 2:30 p.m. close in Cairo. That brings the gauge’s decline this week to 2.5 percent.

The following shares were active on the Egyptian Exchange. Stock symbols follow company names.

Egyptian International Pharmaceutical Industries Co. (PHAR EY) increased 1.5 percent, the most in more than two months, to 34.52 Egyptian pounds. The country’s biggest publicly traded drugmaker, also known as Eipico, said it will pay a 3-pound dividend on May 30 to shareholders as of May 27.

Maridive & Oil Services SAE (MOIL EY) slumped for a second day after reporting a quarterly loss, dropping 7.6 percent to $1.10, the lowest level since the shares were listed in 2007. The Cairo-based offshore services provider reported a first-quarter loss of $947,000 after a profit of $18.9 million a year earlier.

Orascom Construction Industries (OCIC EY) rose for the first time in four days, gaining as much as 2.3 percent to 280 pounds before closing at 275.9 pounds. Egypt’s biggest publicly traded builder said shareholders approved splitting the company’s fertilizer and construction businesses.

The company is seeking approval from the country’s investment authority for the plan and said it’s “realistic” to complete the deal in the third-quarter, the head of investor relations, Omar Darwazah, said by phone today.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.